The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
ConsumerAffairs2d
Ozempic vs. Wegovy: Which is best for weight loss?
FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...
STAT5d
Pharmalittle: We’re reading about generic weight loss drugs, anxiety over a Sanofi deal, and more
India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...
By selling access to copycat weight-loss drugs, WeightWatchers has become a copycat business
The decision by WeightWatchers to prescribe knockoff medication has turned the legendary brand into just another online ...
News Medical on MSN3d
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
valuepenguin6d
Costs and Insurance Coverage for Ozempic, Wegovy & Weight Loss Drugs
This could reduce the cost of Zepbound to $168 per month. Many health insurance plans don't cover the weight loss drug Zepbound because it's so new. It was approved by the FDA at the end of ...
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...